Uchida T, Honda N, Yokota S, Ao T, Ikeda S, Odajima K, Mashimo S, Endo T, Ishibashi A, Koshiba K
Department of Urology, School of Medicine, Kitasato University.
Hinyokika Kiyo. 1987 Jun;33(6):869-76.
Between 1971 and 1984, 179 patients with prostatic cancer were admitted to our Hospital. These cases were studied retrospectively. The greatest number of patients were in their seventies. The patients ranged from 55 to 90 years old with an average age of 72.4 years. The most common symptoms were dysuria, urinary retention, pollakisuria and macrohematuria. About 76% of the chief complaints were related to urinary tract obstruction. There were 64 (35.8%), 21 (11.7%), 38 (21.2%) and 56 (31.3%) cases of stage A, B, C and D, respectively. Prostatic cancer was confirmed histopathologically at transurethral resection in 146 patients, transrectal needle biopsy in 25 patients, open prostatectomy in 3 patients, autopsy in 4 patients, and cryosurgery in 1 patient. The 1-, 3-, and 5-year actual survival rates of 162 cases were 89, 70 and 55%, respectively. The 5-year actual survival rate of stage A, B, C, and D was 72, 67, 55 and 34%, respectively. The 5-year actual survival rate for the cases treated with and without anti-androgen therapy was 72% and 73% for stage A, 66% and 75% for stage B, 58% and 44% for stage C and 37% and 12% for stage D, respectively. The cases treated with anti-androgen therapy was divided into the low dose (diethylstilbestrol less than 300 mg/day or hexestrol less than 30 mg/day) and high dose (diethylstilbestrol greater than or equal to 300 mg/day or hexestrol greater than or equal to 30 mg/day) groups.(ABSTRACT TRUNCATED AT 250 WORDS)
1971年至1984年间,我院收治了179例前列腺癌患者。对这些病例进行了回顾性研究。患者人数最多的年龄段为七十多岁。患者年龄在55岁至90岁之间,平均年龄为72.4岁。最常见的症状是排尿困难、尿潴留、尿频和肉眼血尿。约76%的主要症状与尿路梗阻有关。A、B、C、D期病例分别有64例(35.8%)、21例(11.7%)、38例(21.2%)和56例(31.3%)。146例患者经尿道前列腺切除术后病理确诊为前列腺癌,25例经直肠穿刺活检确诊,3例经开放性前列腺切除术确诊,4例经尸检确诊,1例经冷冻手术确诊。162例患者的1年、3年和5年实际生存率分别为89%、70%和55%。A、B、C、D期的5年实际生存率分别为72%、67%、55%和34%。接受和未接受抗雄激素治疗的病例,A期5年实际生存率分别为72%和73%,B期为66%和75%,C期为58%和44%,D期为37%和12%。接受抗雄激素治疗的病例分为低剂量组(己烯雌酚每日小于300毫克或己烷雌酚每日小于30毫克)和高剂量组(己烯雌酚每日大于或等于300毫克或己烷雌酚每日大于或等于30毫克)。(摘要截选至250词)